Episode 223
Pharmaceutical Tariffs Explained: The Will-They-Won’t-They Story of 2025
October 24, 202519m 57s
Audio is streamed directly from the publisher (media.transistor.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Health Affairs' Jeff Byers welcomes Stacie Dusetzina of Vanderbilt University Medical Center and David Simon of the University of Connecticut back to the pod to the current state of drug prices, how proposed tariffs may impact the pharmaceutical industry, that Pfizer deal, what consumers can expect if tariffs are added to prescription drugs, what exactly TrumpRx is, and more.
Become an Insider today to get access to our third trend report focusing on the influence of private equity in health care.
Related Articles:
Topics
big pharmamartin shkreligoodrxtrumprxtariffsdrug tariffspharma tariffsmark cubandrug pricingprescription prices